EPB41L4A and breast carcinoma: To investigate the clinical relevance of EPB41L4A-AS2 and its biological role in breast cancer, we measured the expression of EPB41L4A-AS2 and its association with clinical and pathological features in 250 breast tumor samples, and further validated our findings using The Cancer Genome Atlas (TCGA) dataset.